CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use this state record to trace the legal requirement, then compare it with the terms an office adds. The full work explains the constitutional case, consent analysis, evidence needed, and protections to demand.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
Arizona · Contract for Care
Arizona Contract for Care — State Requirements and Guidance
What does Arizona require, and which terms come from a particular office? Start with the rule’s scope, exceptions and current version before comparing a patient agreement.
Prescribing statutes
| Authority | Requirement and scope | What it does not establish |
|---|---|---|
| A.R.S. §32-3248 | Limits covered initial Schedule II opioid prescriptions to five days, or fourteen days after surgery. “Initial” depends on the preceding 60 days. Exceptions include specified cancer, traumatic injury, hospice, palliative, skilled-nursing, burn, medication-assisted-treatment and infant-weaning circumstances; read the full list. | Not a five-day limit on every ongoing chronic-pain prescription. |
| A.R.S. §32-3248.01 | The 90-MME provision concerns covered new outpatient Schedule II opioid prescriptions. Exceptions include qualifying continuation within 60 days, certain postsurgical prescriptions and specified care contexts, including chronic intractable pain. The law also provides a specialist-consultation pathway, an unavailability provision and special handling for pain-board-certified physicians. Subsection E addresses qualifying established chronic-intractable-pain patients. | Not an automatic order to taper every established patient to 90 MME. Eligibility for an exception depends on the statutory facts; it does not guarantee a prescription. |
| Antagonist co-prescribing — §32-3248.01(D) | Requires an opioid antagonist when prescribing more than 90 MME under subsections B or C. | Does not prohibit a clinic from adopting broader overdose-prevention precautions. |
| A.R.S. §36-2606(E), (G), (L) | Current text requires review of the preceding 12 months of CSPMP data before each covered Schedule II–IV opioid-analgesic or benzodiazepine prescription and refill. Exceptions address specified hospice/palliative, cancer/dialysis, administration, inpatient/residential and limited acute-care circumstances; an outage provision requires documentation. | Do not substitute the older guideline’s quarterly language for the current statute. Check the exact exception before applying it. |
Which facility rules apply?
Arizona Administrative Code, Title 9, Chapter 10, Supplement 26-1, contains the reorganized Article 20 provisions. The compilation includes changes effective April 6, 2026. Verify a facility’s actual licensure category before applying these rules; this directory has not independently verified each license or clinician’s professional-board status.
- R9-10-2003(D)(4) and (E): licensed pain management clinics need policies addressing opioid risks, consent, monitoring and treatment beyond 30 days, including visit and testing frequency, refills, tapering and substance-use referral. Policies must be consistent with applicable Arizona or national guidelines unless contrary to individual medical judgment.
- R9-10-2005 — Patient Rights: includes privacy and participation protections. Subsection D specifies signed opioid informed consent and its contents, including risks, interactions and alternatives. This section was formerly numbered 2007.
- R9-10-2006 — Medical Records: the current records section, formerly 2008.
- R9-10-2007 — Medication Services: formerly 2005.
- R9-10-2008 — Pain Management Services: formerly 2006; addresses assessment, prescribing workflow and specified exceptions.
- R9-10-120: separate opioid-prescribing requirements for other covered health care institutions expressly exclude Article 20 clinics. Its scope and exceptions must be evaluated separately.
Cross-reference caution: the official compilation retains references in R9-10-2008(C) to R9-10-2007(B), although the reorganized headings place Patient Rights and explicit consent content in R9-10-2005. This page flags the inconsistency rather than silently rewriting the official text. Obtain ADHS clarification if that cross-reference affects a compliance decision.
Guidance and office implementation
The 2018 Arizona Opioid Prescribing Guidelines describe themselves as voluntary consensus guidance and caution against standalone use as a disciplinary standard. Their role must nevertheless be read alongside applicable facility rules that reference guidelines and individual medical judgment. Their older statutory summaries do not override current law.
Risk assessment, discussion of alternatives, reproductive counseling, monitoring and an individualized exit strategy have support in guidance. That does not make every office’s exact fee, privacy waiver, specialist-approval condition, renewal interval or discharge consequence a universal legal requirement.
The CDC 2022 guideline supports individualized decisions and warns against abrupt discontinuation or rapid reductions except when a life-threatening issue requires urgent action. It is guidance, not a guarantee of a particular medication or a substitute for Arizona law.
Questions to put beside any agreement
- What specific statute, rule or professional standard requires this exact term?
- Does that authority apply to this facility, clinician and patient?
- What exceptions, alternatives and patient protections appear in the full document?
- What happens if a result is disputed, a service is unavailable or treatment ends?
Open the document reviews and source register.
Evidence limits: A public document does not confirm current signed use. “Office policy” identifies wording or implementation not established as an exact requirement by the authorities reviewed; it is not a finding of illegality, enforceability or clinical necessity. Facility licensure, clinician profession, payer and federal/tribal rules may change the analysis. Research checked October 13, 2026 UTC.
Arizona facility directory · State requirements and guidance · Evidence library · Method and coverage · Arizona Pain Atlas
Our Legal Case presents Seeds of Vice’s broader legal argument. Listing a practice or reviewing its document is not a court finding about that practice.